FIELD: medicine, leprology. SUBSTANCE: method involves determination of serum blood antibody to native and semisynthetic antigens of Mycobacterium leprae hominis by optical density values. Risk group of leprosy relapse is determined at increase of these indices by 2 and more times as compared with normal ones. EFFECT: improved method of evaluation. 5 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF LEPROSY DIAGNOSIS | 1996 |
|
RU2124730C1 |
METHOD OF IDENTIFICATION OF MYCOBACTERIUM LEPRAE IN PATIENTS WITH DISEASE REGRESSION | 1997 |
|
RU2137137C1 |
METHOD FOR DIAGNOSING LEPROSIS | 2000 |
|
RU2171689C1 |
METHOD OF DETECTION OF SPECIFIC LIVER DISEASE IN LEPROSY PATIENTS | 2009 |
|
RU2403869C1 |
METHOD FOR PREDICTION OF RECURRENCE RISK IN LEPROSY PATIENTS | 2008 |
|
RU2373529C1 |
STRAIN OF BACTERIUM MYCOBACTERIUM AVIUM USED FOR LEPROSY DIAGNOSIS | 1994 |
|
RU2080377C1 |
METHOD OF DIAGNOSIS OF LEPROUS PROCESS ACTIVITY | 2000 |
|
RU2170431C1 |
METHOD FOR PREDICTING LEPROSY PATIENT TREATMENT EFFECTIVENESS | 2003 |
|
RU2247374C1 |
METHOD FOR ASSESSING EFFICIENCY OF THE TREATMENT OF LEPROSY WITH POLYMERASE CHAIN REACTION | 2017 |
|
RU2688156C2 |
METHOD FOR DETERMINING LEPROSY FORM | 2004 |
|
RU2279087C2 |
Authors
Dates
1997-06-27—Published
1993-03-23—Filed